16th KUMAMOTO AIDS Seminar
Program
■ October 7th,Wednesday 　9:00-17:30	■ Poster Session
■ October 8th, Thursday 　13:00-17:45	October 8th, Thursday 　13:00-14:30
■ October 9th, Friday　 9:00-14:45	October 9th, Friday 　11:50-13:30
■ October 7th, Wednesday
Hotel Nikko Kumamoto 9:00-17:30

8:40-9:00 Registration  9:00-9:10 Opening Remarks Hiroaki Mitsuya [NCGM / Kumamoto University] Session I 9:10-10:25 〔75〕 Chairs: Hiroaki Mitsuya & Shuzo Matsushita 9:10-9:55 【45】 O-1-01 Robert Murphy Northwestern University, USA Progress in HIV Therapy 9:55-10:25 【30】 O-1-02 Hiroaki Mitsuya NCGM / Kumamoto University, Japan Structure-guided development of molecular-targeting antiviral agents for treatment of HIV infection and AIDS 10:25-10:40 〔15〕 Coffee Break Session II 10:40-12:10 〔90〕 Chairs: Shinich Oka & Wataru Sugiura 10:40-11:10 【30】 O-1-03 Wataru Sugiura NMC / GSK, Japan Molecular epidemiology of acquired and transmitted drug resistant HIV in Japan 11:10-11:40 【30】 O-1-04 Takeshi Nishijima NCGM, Japan Management of chronic kidney diseases in HIV-1-infected patients in the era of “treatment for all” strategy 11:40-12:10 【30】 O-1-05 Yorifumi Satou Kumamoto University, Japan Clonality of HIV-1-infected cells in PBMCs of HIV-1-infected individuals 12:10-13:30 〔80〕 Lunch Session III 13:30-14:30 〔60〕 Chairs: Seiji Okada & Shinya Suzu 13:30-14:00 【30】 O-1-06 Takeo Kuwata Kumamoto University, Japan Impact of gp41 mutations for escape from a broad neutralizing antibody against SIV 14:00-14:30 【30】 O-1-07 Takamasa Ueno Kumamoto University, Japan Relative resistance of HLA-B to down-regulation by naturally-occurring HIV-1 Nef sequences Session IV 14:30-15:45 〔75〕 Chairs: Tetsuro Matano & Takamasa Ueno 14:30-15:00 【30】 O-1-08 Takuya Yamamoto NIBIO / Kumamoto University, Japan CD150 signal modulation enhances SHIV-specific TFH cell responses 15:00-15:45 【45】 O-1-09 Rebecca Lynch NIAID, NIH, USA Impact of broadly neutralizing antibody VRC01 on HIV-1 after infusion into chronically infected subjects 15:45-16:00 〔15〕 Coffee Break Session V 16:00-16:45 〔45〕 Chair: Masafumi Takiguchi 16:00-16:45 【45】 O-1-10 Victor Appay INSERM, France CD8+ T cell efficacy and preservation of immune resources in HIV infection Session VI 16:45-17:30 〔45〕 Chair: Shuzo Matsushita 16:45-17:30 【45】 O-1-11 Dan H. Barouch Harvard Medical, USA Novel HIV Vaccine and Eradication Strategies

Home (Japanese)

Home (English)

Center for AIDS Research HP